Copeptin Serum Level in Liver Transplant Recipients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03587623

Enrollment

Registered

2018-07-16

Start date

2018-07-04

Completion date

2020-01-31

Last updated

2020-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Copeptin, Liver Cirrhosis, Liver Transplant

Brief summary

The study aim is to measure perioperative copeptin concentration in blood of liver transplant recipients and to assess whether there is a correlation between its level and hemodynamic derangement.

Interventions

None listed

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

\- Patient undergoing liver transplantation

Exclusion criteria

* Serum creatinine \> 1,5 mg/dl * Retransplantation * Patient refusal * CRRT or dialysis preoperatively

Design outcomes

Primary

Measure	Time frame
Serum Copeptin concentration	Baseline, intraoperatively, 1,3,7,21 day postoperatively

Countries

Poland

Outcome results